Form 4: Tenet Healthcare Director Reports Routine Stock Unit Grant and Conversion

Tenet Healthcare Corp. Director Vineeta Agarwala reported the grant of 1,333 restricted stock units and the exercise and subsequent disposition of 1,551 restricted stock units into common stock.

Summary

• Vineeta Agarwala, a Director at Tenet Healthcare Corp. (THC), reported changes in her beneficial ownership of company securities via an SEC Form 4 filing.
• On May 22, 2025, Ms. Agarwala was granted 1,333 Restricted Stock Units (RSUs) under the Company's Stock Incentive Plan. These RSUs are economically equivalent to one share of common stock and are scheduled to vest on May 22, 2026.
• On May 23, 2025, Ms. Agarwala exercised 1,551 previously held Restricted Stock Units, converting them into common stock.
• Concurrently on May 23, 2025, 1,551 shares of common stock were disposed of, likely as part of a cashless exercise or to cover tax obligations related to the RSU conversion.
• Following these reported transactions, Ms. Agarwala directly beneficially owns 3,113 shares of common stock and 1,333 Restricted Stock Units.
• The reporting person has the option to receive up to 37% of the newly granted restricted stock units in cash instead of shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects standard director compensation through equity grants, aligning the director's interests with shareholders. The disposition of shares is likely for tax purposes related to the RSU exercise, which is a common and expected event.

Positives

• The grant of 1,333 Restricted Stock Units to Director Vineeta Agarwala indicates continued compensation and aligns her interests with shareholder value creation.
• The vesting of the newly granted RSUs on May 22, 2026, provides a future incentive for the director's continued engagement and performance.

Negatives

• The disposition of 1,551 shares of common stock, likely for tax withholding or cashless exercise, reduces the director's direct common stock holdings from the exercised RSUs.

Future Outlook

The document primarily details past and current insider transactions and does not provide forward-looking statements or guidance regarding the company's financial performance or strategic direction, beyond the vesting schedule of the granted restricted stock units.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation. It does not provide information relevant to broader industry trends or competitive landscape analysis within the healthcare sector.

Related Party Transactions

• The reported transactions, involving the grant and exercise of equity compensation to a director, constitute related party transactions as they occur between the company and a member of its board of directors.

Stakeholder Impact

• Shareholders: The grant of restricted stock units is a form of non-cash compensation that aligns the director's interests with shareholder value creation. The disposition of shares, likely for tax purposes, is a routine part of equity compensation.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• The 1,333 Restricted Stock Units granted on May 22, 2025, are scheduled to vest on May 22, 2026.

Key Dates

Keywords

SEC Form 4, Tenet Healthcare, THC, Vineeta Agarwala, Director, Restricted Stock Units, RSU, Insider Transaction, Stock Compensation, Beneficial Ownership, Equity Grant